Here’s a new Watchlist with new additions to the list. The goal of this list is to identify stocks breaking out into new Stage 2 advances, which is an ideal time to purchase a stock that is getting ready to make a major move. The list will be pruned over time by removing stocks that have already made major runs, or removing stocks that breakdown into Stage 4 declines. The list will include names in Stage 4 declines that are possibly getting close to ending as well.
I entered into a position in ANGI, which is still techincally in a Stage 4 decline, but it is close to breaking above its 30-week moving average. ANGI had a breakaway gap on monster volume after earnings, and it’s likely that gap could end its Stage 4 decline, which is why I took a position. ANGI also has a large short position against it which could provide fuel for a new advance.
Of the names currently on the Watchlist I also like CHGG. It has a nice year long base and broke out recently on big volume into a Stage 2.
Stage Analysis: Watchlist Report
Ticker | Stage | Weeks | Links |
FSLR | 1 | 1 | D W F Y G |
SPWR | 1 | 1 | D W F Y G |
RNF | 1 | 2 | D W F Y G |
TWTR | 1 | 3 | D W F Y G |
AMKR | 1 | 3 | D W F Y G |
ROSG | 1 | 4 | D W F Y G |
BBRY | 2 | 1 | D W F Y G |
CHGG | 2 | 1 | D W F Y G |
TILE | 2 | 1 | D W F Y G |
CLRX | 2 | 1 | D W F Y G |
GT | 2 | 2 | D W F Y G |
RNG | 2 | 3 | D W F Y G |
ANTH | 2 | 3 | D W F Y G |
FEYE | 2 | 3 | D W F Y G |
ARIA | 2 | 3 | D W F Y G |
SPLK | 2 | 3 | D W F Y G |
GENE | 2 | 4 | D W F Y G |
SUNE | 2 | 4 | D W F Y G |
MVNR | 2 | 4 | D W F Y G |
AMZN | 2 | 4 | D W F Y G |
PPO | 2 | 4 | D W F Y G |
MCHP | 2 | 5 | D W F Y G |
RGLD | 2 | 6 | D W F Y G |
DNA.TO | 2 | 6 | D W F Y G |
SCIF | 2 | 7 | D W F Y G |
CUBI | 2 | 7 | D W F Y G |
MRVL | 2 | 10 | D W F Y G |
OPK | 2 | 10 | D W F Y G |
SLAB | 2 | 11 | D W F Y G |
ARRY | 2 | 11 | D W F Y G |
HASI | 2 | 11 | D W F Y G |
RUBI | 2 | 11 | D W F Y G |
CLDX | 2 | 12 | D W F Y G |
SIMO | 2 | 13 | D W F Y G |
POT | 2 | 13 | D W F Y G |
DE | 2 | 13 | D W F Y G |
AVG | 2 | 13 | D W F Y G |
CODE | 2 | 15 | D W F Y G |
SLGN | 2 | 15 | D W F Y G |
TNA | 2 | 15 | D W F Y G |
PAYC | 2 | 15 | D W F Y G |
TSEM | 2 | 16 | D W F Y G |
UWM | 2 | 16 | D W F Y G |
PLCM | 2 | 16 | D W F Y G |
EBIX | 2 | 16 | D W F Y G |
FLTX | 2 | 16 | D W F Y G |
TNK | 2 | 17 | D W F Y G |
NXPI | 2 | 18 | D W F Y G |
SJM | 2 | 18 | D W F Y G |
IPGP | 2 | 18 | D W F Y G |
APH | 2 | 18 | D W F Y G |
AGU | 2 | 18 | D W F Y G |
RGLS | 2 | 19 | D W F Y G |
MTSN | 2 | 24 | D W F Y G |
TNAV | 2 | 26 | D W F Y G |
INFN | 2 | 28 | D W F Y G |
DEPO | 2 | 28 | D W F Y G |
KSS | 2 | 30 | D W F Y G |
SWIR | 2 | 30 | D W F Y G |
AMBA | 2 | 37 | D W F Y G |
PTLA | 2 | 37 | D W F Y G |
BPY | 2 | 42 | D W F Y G |
MOH | 2 | 44 | D W F Y G |
EXR | 2 | 58 | D W F Y G |
CVTI | 2 | 75 | D W F Y G |
MU | 3 | 7 | D W F Y G |
AUQ | 4 | 2 | D W F Y G |
SGNL | 4 | 6 | D W F Y G |
STLD | 4 | 7 | D W F Y G |
BNFT | 4 | 7 | D W F Y G |
X | 4 | 9 | D W F Y G |
PLM | 4 | 21 | D W F Y G |
TGD | 4 | 23 | D W F Y G |
WYNN | 4 | 25 | D W F Y G |
LVS | 4 | 29 | D W F Y G |
URG | 4 | 41 | D W F Y G |
ANGI | 4 | 54 | D W F Y G |
Stage 1 | Stage 2 | Stage 3 | Stage 4 |
7.8% | 76.7% | 1.3% | 14.3% |
Stage Transitions: Watchlist Report
Ticker | From | To | Links |
FSLR | 4 | 1 | D W F Y G |
SPWR | 4 | 1 | D W F Y G |
BBRY | 3 | 2 | D W F Y G |
CHGG | 4 | 2 | D W F Y G |
TILE | 1 | 2 | D W F Y G |
CLRX | 1 | 2 | D W F Y G |